Semin Neurol 2017; 37(06): 669-678
DOI: 10.1055/s-0037-1608940
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Stroke in Pregnancy

Christina Mijalski Sells
1   Department of Neurology, Stanford University Medical Center, Stanford Stroke Center, Palo Alto, California
,
Steven K. Feske
2   Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts
› Author Affiliations
Further Information

Publication History

Publication Date:
21 December 2017 (online)

Abstract

Pregnancy and the postpartum period confer an increased risk of stroke. The risk appears to be increased for all strokes during the puerperium and for hemorrhagic strokes during pregnancy. During pregnancy, physiologic systems are under increased stress to accommodate the growing fetus, which results in substantial hemodynamic, cardiovascular, hematologic, immunologic, and structural connective tissue changes that account for much of this increased risk. In addition, preeclampsia–eclampsia has major effects on the vascular system, and this disorder, unique to pregnancy, is another major contributor to this risk. The common independent vascular risk factors for stroke, such as hypertension, diabetes, hyperlipidemia, and smoking, may also be present to contribute to the risks conferred by pregnancy. Though uncommon, stroke during pregnancy and in the postpartum period causes substantial morbidity and mortality in affected women, and it poses a significant risk to the fetus. This review will discuss the epidemiology of pregnancy-associated stroke, specific risk factors and mechanisms, clinical presentation and management, and future directions.

 
  • References

  • 1 Petitti DB, Sidney S, Quesenberry Jr CP, Bernstein A. Incidence of stroke and myocardial infarction in women of reproductive age. Stroke 1997; 28 (02) 280-283
  • 2 Kittner SJ, Stern BJ, Feeser BR. , et al. Pregnancy and the risk of stroke. N Engl J Med 1996; 335 (11) 768-774
  • 3 Ban L, Sprigg N, Abdul Sultan A. , et al. Incidence of First Stroke in Pregnant and Nonpregnant Women of Childbearing Age: A Population-Based Cohort Study From England. J Am Heart Assoc 2017; 6 (04) e004601
  • 4 Feske SK. Stroke in pregnancy. Semin Neurol 2007; 27 (05) 442-452
  • 5 Sharshar T, Lamy C, Mas JL. ; Stroke in Pregnancy Study Group. Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke 1995; 26 (06) 930-936
  • 6 Liang CC, Chang SD, Lai SL, Hsieh CC, Chueh HY, Lee TH. Stroke complicating pregnancy and the puerperium. Eur J Neurol 2006; 13 (11) 1256-1260
  • 7 Jeng JS, Tang SC, Yip PK. Incidence and etiologies of stroke during pregnancy and puerperium as evidenced in Taiwanese women. Cerebrovasc Dis 2004; 18 (04) 290-295
  • 8 Vladutiu CJ, Meyer ML, Malek AM. , et al. Racial Differences in the Association between Parity and Incident Stroke: Results from the REasons for Geographic and Racial Differences in Stroke Study. J Stroke Cerebrovasc Dis 2017; 26 (04) 749-755
  • 9 Cheng CA, Lee JT, Lin HC. , et al. Pregnancy increases stroke risk up to 1 year postpartum and reduces long-term risk. QJM 2017; 110 (06) 355-360
  • 10 Yoshida K, Takahashi JC, Takenobu Y, Suzuki N, Ogawa A, Miyamoto S. Strokes Associated With Pregnancy and Puerperium: A Nationwide Study by the Japan Stroke Society. Stroke 2017; 48 (02) 276-282
  • 11 Kuklina EV, Tong X, Bansil P, George MG, Callaghan WM. Trends in pregnancy hospitalizations that included a stroke in the United States from 1994 to 2007: reasons for concern?. Stroke 2011; 42 (09) 2564-2570
  • 12 Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000; 31 (06) 1274-1282
  • 13 Miller EC, Gatollari HJ, Too G. , et al. Risk of Pregnancy-Associated Stroke Across Age Groups in New York State. JAMA Neurol 2016; 73 (12) 1461-1467
  • 14 Brown DW, Dueker N, Jamieson DJ. , et al. Preeclampsia and the risk of ischemic stroke among young women: results from the Stroke Prevention in Young Women Study. Stroke 2006; 37 (04) 1055-1059
  • 15 Lenfant C. ; National Education Program Working Group on High Blood Pressure in Pregnancy. Working group report on high blood pressure in pregnancy. J Clin Hypertens (Greenwich) 2001; 3 (02) 75-88
  • 16 Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357 (9249): 53-56
  • 17 Feske SK, Singhal AB. Cerebrovascular disorders complicating pregnancy. Continuum (Minneap Minn) 2014; 20 (1 Neurology of Pregnancy): 80-99
  • 18 Wickström K, Edelstam G, Löwbeer CH, Hansson LO, Siegbahn A. Reference intervals for plasma levels of fibronectin, von Willebrand factor, free protein S and antithrombin during third-trimester pregnancy. Scand J Clin Lab Invest 2004; 64 (01) 31-40
  • 19 Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 1997; 73 (01) 31-36
  • 20 Caplan LR. Uncommon Causes of Stroke. 2nd ed. United Kingdom: Cambridge University Press; 2008: 560
  • 21 Raps EC, Galetta SL, Broderick M, Atlas SW. Delayed peripartum vasculopathy: cerebral eclampsia revisited. Ann Neurol 1993; 33 (02) 222-225
  • 22 Donaldson JO. Eclampsia and postpartum cerebral angiopathy. J Neurol Sci 2000; 178 (01) 1
  • 23 Singhal AB. Postpartum angiopathy with reversible posterior leukoencephalopathy. Arch Neurol 2004; 61 (03) 411-416
  • 24 Tang CH, Wu CS, Lee TH. , et al. Preeclampsia-eclampsia and the risk of stroke among peripartum in Taiwan. Stroke 2009; 40 (04) 1162-1168
  • 25 Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ 2007; 335 (7627): 974
  • 26 Edvinsson L, Owman C, Sjöberg NO. Autonomic nerves, mast cells, and amine receptors in human brain vessels. A histochemical and pharmacological study. Brain Res 1976; 115 (03) 377-393
  • 27 Veltkamp R, Kupsch A, Polasek J, Yousry TA, Pfister HW. Late onset postpartum eclampsia without pre-eclamptic prodromi: clinical and neuroradiological presentation in two patients. J Neurol Neurosurg Psychiatry 2000; 69 (06) 824-827
  • 28 Qureshi AI, Frankel MR, Ottenlips JR, Stern BJ. Cerebral hemodynamics in preeclampsia and eclampsia. Arch Neurol 1996; 53 (12) 1226-1231
  • 29 Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988; 19 (03) 326-329
  • 30 Call GK, Fleming MC, Sealfon S, Levine H, Kistler JP, Fisher CM. Reversible cerebral segmental vasoconstriction. Stroke 1988; 19 (09) 1159-1170
  • 31 Singhal AB, Hajj-Ali RA, Topcuoglu MA. , et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol 2011; 68 (08) 1005-1012
  • 32 Saposnik G, Barinagarrementeria F, Brown Jr RD. , et al; American Heart Association Stroke Council and the Council on Epidemiology and Prevention. Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011; 42 (04) 1158-1192
  • 33 Ferro JM, Canhão P, Stam J, Bousser MG, Barinagarrementeria F. ; ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 2004; 35 (03) 664-670
  • 34 Patten IS, Rana S, Shahul S. , et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 2012; 485 (7398): 333-338
  • 35 Elkayam U, Akhter MW, Singh H. , et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005; 111 (16) 2050-2055
  • 36 Mohr JP, Kejda-Scharler J, Pile-Spellman J. Diagnosis and treatment of arteriovenous malformations. Curr Neurol Neurosci Rep 2013; 13 (02) 324
  • 37 Jaigobin C, Silver FL. Stroke and pregnancy. Stroke 2000; 31 (12) 2948-2951
  • 38 Dias MS, Sekhar LN. Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium. Neurosurgery 1990; 27 (06) 855-865 , discussion 865–866
  • 39 Powers WJ, Derdeyn CP, Biller J. , et al; American Heart Association Stroke Council. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2015; 46 (10) 3020-3035
  • 40 Del Zotto E, Giossi A, Volonghi I, Costa P, Padovani A, Pezzini A. Ischemic Stroke during Pregnancy and Puerperium. Stroke Res Treat 2011; 2011: 606780
  • 41 Leonhardt G, Gaul C, Nietsch HH, Buerke M, Schleussner E. Thrombolytic therapy in pregnancy. J Thromb Thrombolysis 2006; 21 (03) 271-276
  • 42 Murugappan A, Coplin WM, Al-Sadat AN. , et al. Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology 2006; 66 (05) 768-770
  • 43 Johnson DM, Kramer DC, Cohen E, Rochon M, Rosner M, Weinberger J. Thrombolytic therapy for acute stroke in late pregnancy with intra-arterial recombinant tissue plasminogen activator. Stroke 2005; 36 (06) e53-e55
  • 44 Altman D, Carroli G, Duley L. , et al; Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002; 359 (9321): 1877-1890
  • 45 The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345 (8963): 1455-1463
  • 46 Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333 (04) 201-205
  • 47 Witlin AG, Friedman SA, Egerman RS, Frangieh AY, Sibai BM. Cerebrovascular disorders complicating pregnancy–beyond eclampsia. Am J Obstet Gynecol 1997; 176 (06) 1139-1145 , discussion 1145–1148
  • 48 Wiebers DO, Whisnant JP. The incidence of stroke among pregnant women in Rochester, Minn, 1955 through 1979. JAMA 1985; 254 (21) 3055-3057
  • 49 Dapprich M, Boessenecker W. Fibrinolysis with alteplase in a pregnant woman with stroke. Cerebrovasc Dis 2002; 13 (04) 290
  • 50 Wiese KM, Talkad A, Mathews M, Wang D. Intravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke. Stroke 2006; 37 (08) 2168-2169
  • 51 Yamaguchi Y, Kondo T, Ihara M. , et al. Intravenous recombinant tissue plasminogen activator in an 18-weeks pregnant woman with embolic stroke. Clin Neurol 2010; 50: 315-319
  • 52 Hori H, Yamamoto F, Ito Y, Hashimoto Y, Hirano T, Uchino M. [Intravenous recombinant tissue plasminogen activator therapy in a 14-week pregnant woman with embolic stroke due to protein S deficiency]. Rinsho Shinkeigaku 2013; 53 (03) 212-216
  • 53 Tassi R, Acampa M, Marotta G. , et al. Systemic thrombolysis for stroke in pregnancy. Am J Emerg Med 2013; 31 (02) 448.e1-448.e3
  • 54 Mantoan Ritter L, Schüler A, Gangopadhyay R. , et al. Successful thrombolysis of stroke with intravenous alteplase in the third trimester of pregnancy. J Neurol 2014; 261 (03) 632-634